Downstreamthe daily issueevery agency

Health and Human Services Department

554 documents across 55 days of the archive, 39 of them final rules. The five most recent days are below.

Dates this agency has set that have not yet arrived

What is in this list

Comment deadlines and effective dates from anything this agency published in the archive, still ahead of 29 October 2026.

Dates set before this archive began are not here, and their absence is not evidence that none exist.

as_of

  1. today Comments close Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; National Marrow Donor Program Patient Support Center Survey Health and Human Services Department · Health Resources and Services Administration
  2. today Comments close Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 Health and Human Services Department · Food and Drug Administration
  3. +1d Comments close Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act and Associated Fees Health and Human Services Department · Food and Drug Administration
  4. +1d Comments close Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Reports of Removals and Corrections Health and Human Services Department · Food and Drug Administration
  5. +4d Comments close Agency Information Collection Activities: Proposed Collection; Comment Request Health and Human Services Department · Centers for Medicare & Medicaid Services
  6. +4d Comments close Emergency Office of Management and Budget Review and Public Comment: Questionnaire for the Refugee Outreach and Well-Being Initiative Health and Human Services Department · Children and Families Administration
  7. +4d Comments close Agency Information Collection Activities: Submission for OMB Review; Comment Request Health and Human Services Department · Centers for Medicare & Medicaid Services
  8. +4d Comments close Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Improvement Program Health and Human Services Department · Food and Drug Administration
  9. +5d Comments close Advancing Development of Botanical Drug Products; Request for Information Health and Human Services Department · Food and Drug Administration
  10. +5d Takes effect Requirement for Attestation for All Airline or Other Aircraft Passengers Arriving in the United States From Any Foreign Country and Controlled Free Pratique for Airlines Confirming That Such Passengers Have Not Been in the Democratic Republic of the Congo in the Past 21 Days Health and Human Services Department · Centers for Disease Control and Prevention
  11. +6d Comments close Submission for Office of Management and Budget Review; Federal Case Registry Health and Human Services Department · Children and Families Administration
  12. +6d Comments close Agency Information Collection Activities: Proposed Collection; Comment Request Health and Human Services Department · Agency for Healthcare Research and Quality
  13. +6d Comments close Agency Information Collection Activities: Proposed Collection; Comment Request Health and Human Services Department · Agency for Healthcare Research and Quality
  14. +6d Comments close Reforming Federal Reporting and Assessments in Child Welfare Health and Human Services Department · Children and Families Administration
  15. +6d Comments close Submission for Office of Management and Budget Review; Mental Health Assessment Form and Onsite Health Intervention Form Health and Human Services Department · Children and Families Administration
  16. +8d Comments close Agency Information Collection Activities: Submission for OMB Review; Comment Request Health and Human Services Department · Centers for Medicare & Medicaid Services
  17. +11d Comments close Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Bureau of Health Workforce Performance Data Collection, OMB No. 0906-0086-Revision Health and Human Services Department · Health Resources and Services Administration
  18. +11d Comments close Proposed Data Collection Submitted for Public Comment and Recommendations Health and Human Services Department · Centers for Disease Control and Prevention
  19. +11d Comments close Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products Health and Human Services Department · Food and Drug Administration
  20. +11d Comments close Agency Information Collection Activities; Proposed Collection; Comment Request; Pregnancy Exposure Registry Enrollment Project: A Survey of Health Care Providers To Advance Pregnancy Safety Data Collection and Improve Health Communications Health and Human Services Department · Food and Drug Administration
  21. +11d Comments close Improving Patient Access to Deceased Donor Islet Cells and Cell Products; Request for Information Health and Human Services Department · Food and Drug Administration · Health Resources and Services Administration
  22. +11d Comments close Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Event Program for Medical Devices: (Medical Product Safety Network (MedSun)) Health and Human Services Department · Food and Drug Administration
  23. +11d Comments close Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biologics License Applications, Procedures and Requirements Health and Human Services Department · Food and Drug Administration
  24. +11d Comments close Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use Health and Human Services Department · Food and Drug Administration
  25. +11d Comments close Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Data System for Organ Procurement and Transplantation Network, OMB No. 0906-0110-Revision Health and Human Services Department · Health Resources and Services Administration
  26. +11d Comments close Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Applicant Organizational National Provider Identifiers and Centers for Medicare & Medicaid Services Certification Numbers Form Health and Human Services Department · Health Resources and Services Administration
  27. +12d Comments close Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Health Network Development Program Performance Improvement and Measurement System, OMB No. 0906-0010-Revision Health and Human Services Department · Health Resources and Services Administration
  28. +12d Comments close Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Tracking Health and Human Services Department · Food and Drug Administration
  29. +14d Comments close Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Healthy Start Evaluation and Quality Improvement, OMB No. 0915-0338-Revision Health and Human Services Department · Health Resources and Services Administration
  30. +14d Comments close Announcing Solicitation of Written Comments To Inform the Physical Activity Guidelines for Americans, 2nd Edition Supplement: 2027 Steps and Muscle-Strengthening Guidance Health and Human Services Department

100 more beyond these.

29 October 2026 19 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

HHS published 19 documents including three proposed rules on block grants and federal workplace drug testing guidelines, one final rule on child support enforcement, and fifteen notices.

Post on X Post on LinkedIn Permalink

Proposed RuleHealth and Human Services DepartmentChildren and Families Administration

Reducing Bureaucracy and Burden for Block Grants

ACF proposes to amend its block grant regulations to modernize requirements, reduce administrative burden on States and Tribal grantees, and improve the clarity and efficiency of program administration. The current regulations include outdated provisions and procedural requirements that no longer reflect statutory authority or agency practice. The proposed revisions are intended to streamline grantee obligations, eliminate unnecessary requirements, and align the regulations with current law and policy.

  • Comments close in 32 days

91 FR 68097FR Doc. 2026-22123official PDFfederalregister.gov

RuleHealth and Human Services DepartmentChildren and Families Administration

Reducing Bureaucracy and Burden for Child Support Enforcement Programs

This final rule amends the Child Support regulations that were unnecessary or obsolete in the following sections: State Plan Approval and Grant Procedures, State Plan Requirements, Standards for Program Operations, Federal Financial Participation, Program Performance Measures, Standards, Financial Incentives, and Penalties, Computerized Support Enforcement Systems, Annual State Self-Assessment Review and Report, Tribal Child Support Enforcement (IV-D) Program, and Computerized Tribal IV-D Systems and Office Automation.

  • Takes effect in 32 days

91 FR 68045FR Doc. 2026-22116official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentCenters for Medicare & Medicaid Services

Agency Information Collection Activities: Submission for OMB Review; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

  • Comments close in 32 days

91 FR 68150FR Doc. 2026-22106official PDFfederalregister.gov

NoticeHealth and Human Services Department

Agency Information Collection Request. 60-Day Public Comment Request

In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services (HHS), the Assistant Secretary for Planning and Evaluation (ASPE) is inviting public comment on an extension request for an approved information collection request: ASPE Umbrella Generic Clearance for the Collection of Qualitative Research and Assessment (OMB #0990-0421). No changes are proposed to the purpose and use described within this generic, but burden estimates have been adjusted to reflect estimated use over the next three years.

  • Comments close in 60 days

91 FR 68153FR Doc. 2026-22096official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentCenters for Medicare & Medicaid Services

Privacy Act of 1974; Matching Program

In accordance with subsection (e)(12) of the Privacy Act of 1974, as amended, the Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS), is providing notice of a computer matching program between CMS and participating State-Based Administering Entities (AEs), titled "Determining Eligibility for Enrollment in Applicable State Health Subsidy Programs Under the Patient Protection and Affordable Care Act". The matching program supports eligibility determinations for enrollment in applicable State health subsidy programs under the Patient Protection and Affordable Care Act (PPACA), including Qualified Health Plans (QHPs), Medicaid, the Children's Health Insurance Program (CHIP), and Basic Health Programs (BHPs). The matching program also supports implementation of statutory requirements concerning Medicaid community engagement and the prevention of concurrent Medicaid enrollment in more than one State through the Multi-State Enrollment Prevention (MSEP) system.

  • Comments close in 32 days

91 FR 68151FR Doc. 2026-22015official PDFfederalregister.gov

28 October 2026 15 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

HHS published a final rule on health data technology interoperability and fourteen notices on October 28, 2026, including draft guidance on genome editing products and IDE submissions.

Post on X Post on LinkedIn Permalink

NoticeHealth and Human Services DepartmentAgency for Healthcare Research and Quality

Agency Information Collection Activities: Proposed Collection; Comment Request

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the extension without change of the currently approved information collection "Questionnaire and Data Collection Testing, Evaluation, and Research for the Agency for Healthcare Research and Quality" (OMB #0935-0124).

  • Comments close in 60 days

91 FR 67834FR Doc. 2026-21985official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document titled "Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management." The draft guidance document provides recommendations for how an individualized human genome editing (GE) product that includes multiple product variants can be submitted in a single Biologics License Application (BLA). When finalized, this guidance will describe the FDA's current thinking on individualized GE products with respect to how to specify the extent of GE component variation in a BLA, how to add new product variants to the BLA after licensure, and related topics.

  • Comments close in 29 days

91 FR 67838FR Doc. 2026-21954official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Electronic Submission Template for Investigational Device Exemption (IDE) Applications; Draft Guidance for Sponsors and Food and Drug Administration Staff; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance titled "Electronic Submission Template for Investigational Device Exemption (IDE) Applications." FDA is issuing this draft guidance for sponsors submitting IDE applications to the Center for Devices and Radiological Health (CDRH) and Center for Biologics Evaluation and Research (CBER). It introduces those sponsors to the current publicly available resources and associated content developed to support IDE electronic submissions to FDA. This draft guidance, when finalized, is intended to represent one of several steps in meeting FDA's commitment to the development of electronic submission templates to serve as guided submission preparation tools for sponsors to improve submission consistency and enhance efficiency in the review process. This draft guidance is not final nor is it for implementation at this time.

  • Comments close in 60 days

91 FR 67840FR Doc. 2026-21953official PDFfederalregister.gov

RuleSIGNIFICANT · E.O. 12866Health and Human Services DepartmentOffice of the Secretary

Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity

This final rule focuses on deregulatory actions identified in HHS regulations regarding health information technology standards, implementation specifications, and certification criteria and regarding certification programs for health information technology. This final rule reduces burden, offers flexibility to both developers and providers, and supports innovation through the removal and revision of certain certification criteria and regulatory provisions.

  • Takes effect in 60 days

91 FR 67916FR Doc. 2026-21943official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on "Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs."

  • Comments close in 60 days

91 FR 67845FR Doc. 2026-21914official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Color Additive Certification

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

  • Comments close in 29 days

91 FR 67842FR Doc. 2026-21913official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Rapid Response Surveys

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the use of rapid response surveys to obtain data on safety information that supports quick turnaround decision making about potential safety problems or risk management solutions.

  • Comments close in 60 days

91 FR 67843FR Doc. 2026-21912official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; EMCITATE (Tiratricol)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that EMCITATE (tiratricol), approved September 28, 2026, manufactured by Rare Thyroid Therapeutics International AB meets the criteria for a priority review voucher.

91 FR 67840FR Doc. 2026-21911official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ATEBRIOZ (Zilurgisertib)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that ATEBRIOZ (zilurgisertib), approved September 25, 2026, manufactured by Incyte Corporation meets the criteria for a priority review voucher.

91 FR 67839FR Doc. 2026-21910official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure (MCM) Priority Review Voucher; Bixlenvo (Bictegravir and Lenacapavir)

The Food and Drug Administration (FDA) is announcing the approval of a product redeeming a material threat MCM priority review voucher. The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the 21st Century Cures Act (Cures Act), authorizes FDA to award priority review vouchers to sponsors of approved material threat MCM product applications that meet certain criteria. FDA is required to publish notice of the issuance of material threat MCM priority review vouchers as well as the approval of products redeeming a voucher. FDA has determined that Bixlenvo (bictegravir and lenacapavir), tablets, approved August 27, 2026, meet the redemption criteria.

91 FR 67835FR Doc. 2026-21909official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Records; Electronic Signatures

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection applicable to the electronic record signature provisions found in Agency regulations.

  • Comments close in 60 days

91 FR 67836FR Doc. 2026-21908official PDFfederalregister.gov

27 October 2026 10 documents

No sentence for this date — either it has not been generated yet, or it was withheld by the fidelity gate.

NoticeHealth and Human Services DepartmentNational Institutes of Health

Government-Owned Inventions; Availability for Licensing

The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.

91 FR 67593FR Doc. 2026-21905official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentNational Institutes of Health

Submission for OMB Review; 30-Day Comment Request; The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research

In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.

  • Takes effect in 29 days

91 FR 67592FR Doc. 2026-21904official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Determination That PEPCID RPD (Famotidine) Orally Disintegrating Tablets, 20 Milligrams and 40 Milligrams Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that PEPCID RPD (famotidine) orally disintegrating tablets, 20 milligrams (mg) and 40 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for famotidine) orally disintegrating tablets, 20 mg and 40 mg, if all other legal and regulatory requirements are met.

91 FR 67587FR Doc. 2026-21897official PDFfederalregister.gov

Proposed RuleHealth and Human Services Department

Patient Protection and Affordable Care Act, Exchange Pre-Eligibility Verification

This proposed rule would implement new requirements specified under the Working Families Tax Cut (WFTC) legislation related to Exchange eligibility and verification. This proposed rule contains related updates to provisions affecting inconsistency periods, inconsistency verification procedures, annual eligibility redeterminations and eligibility redeterminations during the plan year, as well as expanding enrollment methods during the verification process and establishing new coverage effective dates.

  • Comments close in 29 days

91 FR 67656FR Doc. 2026-21891official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentHealth Resources and Services Administration

Agency Information Collection Activities: Submission to OMB for Review and Approval: Public Comment Request; Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.

  • Comments close 2 days ago

91 FR 67589FR Doc. 2026-21857official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

U.S.-Origin Statements on Seafood; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or we) is announcing the availability of a draft guidance for industry entitled "U.S.-Origin Statements on Seafood." The draft guidance, when finalized, will provide examples of U.S.-origin statements in seafood product labeling that FDA would consider to be truthful and not misleading.

  • Comments close in 60 days

91 FR 67588FR Doc. 2026-21838official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentCenters for Disease Control and Prevention

Proposed Data Collection Submitted for Public Comment and Recommendations

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled 2026 Ebola Passenger Disclosure and Attestation. The purpose of this information collection is to ensure that, consistent with the terms of a pending Order under the Public Health Service Act, public health authorities in the United States can confirm that individuals have not been present in the Democratic Republic of the Congo (DRC) in the 21 days before arriving in the United States.

  • Comments close in 60 days

91 FR 67580FR Doc. 2026-21831official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentCenters for Disease Control and Prevention

Proposed Data Collection Submitted for Public Comment and Recommendations

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Tuberculosis (TB) Laboratory Services Survey. This project will conduct a comprehensive, national update of a prior tuberculosis (TB) laboratory services assessment by collecting current information on U.S. laboratories' capacity, capabilities, and accessibility to deliver high-quality mycobacteriology diagnostic services.

  • Comments close in 60 days

91 FR 67579FR Doc. 2026-21830official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentCenters for Disease Control and Prevention

Requirement for Attestation for All Airline or Other Aircraft Passengers Arriving in the United States From Any Foreign Country and Controlled Free Pratique for Airlines Confirming That Such Passengers Have Not Been in the Democratic Republic of the Congo in the Past 21 Days

The Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), announces it is issuing an Order under Sections 361, 365, 368, and 369 of the Public Health Service Act, and associated implementing regulations, prohibiting the boarding of any passenger who is not otherwise subject to an exemption on any aircraft destined to the United States from a foreign country unless the passenger presents a signed attestation confirming the passenger has not been present in the Democratic Republic of the Congo (DRC) during the 21 days prior to boarding a flight to the United States. This Order was issued on October 22, 2026, to become effective at 11:59 p.m. Eastern Standard Time (EST) on November 3, 2026, and shall remain in effect through 11:59 p.m. EST on December 18, 2026. This Order may be amended or rescinded prior to that time at the discretion of the Secretary or his designee.

  • Takes effect in 5 days

91 FR 67582FR Doc. 2026-21828official PDFfederalregister.gov

26 October 2026 5 documents

No sentence for this date — either it has not been generated yet, or it was withheld by the fidelity gate.

NoticeHealth and Human Services DepartmentChildren and Families Administration

Submission for Office of Management and Budget Review; Office of Refugee Resettlement (ORR) Unaccompanied Alien Child Health Forms

The Administration for Children and Families (ACF) Office of Refugee Resettlement (ORR) is requesting to move the Serious Medical Procedure Request (SMR) Form (Office of Management and Budget (OMB) #: 0970-0561, expiration December 31, 2026) under the Medical Assessment Form and Dental Assessment Form (OMB #: 0970-0466, expiration 10/31/ 2026) information collection and update the title of OMB # 0970-0466 to Office of Refugee Resettlement (ORR) Unaccompanied Alien Child Health Forms. Revisions are proposed to the forms. The proposed restructuring and revisions will improve transparency, lessen burden, improve data quality, and ensure alignment with ORR requirements. In addition, to ensure continuity of care, the request has been revised to include the sharing of health information with the Department of Homeland Security (DHS) in specific circumstances.

  • Comments close in 27 days

91 FR 67320FR Doc. 2026-21762official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ISEMBYLD (apitegromab-mstn)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that ISEMBYLD (apitegromab-mstn), approved September 11, 2026, manufactured by Scholar Rock, Inc., meets the criteria for a priority review voucher.

91 FR 67321FR Doc. 2026-21718official PDFfederalregister.gov

23 October 2026 16 documents

Machine-written from the fields above · claude-haiku-4-5-20251001

The Food and Drug Administration published 14 notices and 2 proposed rules on information collections, product guidance, and regulatory determinations.

Post on X Post on LinkedIn Permalink

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Proposed Collection; Comment Request; Export Certificates for FDA Regulated Products

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on export certificates for FDA regulated products.

  • Comments close in 54 days

91 FR 66848FR Doc. 2026-21714official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Proposed Collection; Comment Request; Product Jurisdiction and Combination Products

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with product jurisdiction and combination product regulations.

  • Comments close in 54 days

91 FR 66852FR Doc. 2026-21713official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accreditation Scheme for Conformity Assessment Program

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

  • Comments close in 25 days

91 FR 66845FR Doc. 2026-21712official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Determination of Regulatory Review Period for Purposes of Patent Extension; Correction of Notices-ANDEMBRY; ANZUPGO; ANKTIVA; BIZENGRI; BRINSUPRI; DAYVIGO

The Food and Drug Administration (FDA) is announcing corrections to the notices of Determination of Regulatory Review Period for Purposes of Patent Extension for ANDEMBRY; ANZUPGO; ANKTIVA; BIZENGRI; BRINSUPRI; and DAYVIGO. The original determinations were announced in the Federal Registers of August 10, 2026 (BRINSUPRI, DAYVIGO), August 17, 2026 (BIZENGRI), and September 9, 2026 (ANDEMBRY, ANZUPGO, ANKTIVA). Those notices correctly identified the dates on which the testing and approval phases began and ended but incorrectly stated the length of the regulatory review period due to calculation errors. No other changes are made.

91 FR 66851FR Doc. 2026-21711official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentChildren and Families Administration

Proposed Information Collection Activity; Child Care and Development Fund Plan Preprint for States/Territories for Federal Fiscal Year (FFY) 2028-2030 (ACF-118) and extension of Child Care and Development Fund Plan Preprint for States/Territories for FFY 2025-2027

The Administration for Children and Families (ACF) is requesting an extension without changes of the form ACF-118: Child Care and Development Fund (CCDF) Plan Preprint for States/Territories for FFY 2025-2027 (Office of Management and Budget #: 0970-0114, expiration March 31, 2027), and an additional 3-year extension of the form ACF- 118: CCDF Plan Preprint for States/Territories for FFY 2028-2030. There are changes requested to the form ACF-118: CCDF Plan Preprint for States/Territories for FFY 2028-2030 to reduce burden, streamline questions, reduce data entry, and strengthen program integrity.

  • Comments close in 54 days

91 FR 66844FR Doc. 2026-21703official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentFood and Drug Administration

Questions and Answers Regarding Mandatory Cosmetics Recalls; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Questions and Answers Regarding Mandatory Cosmetics Recalls: Guidance for Industry." The guidance document provides answers to common questions that might arise about FDA's mandatory recall authority for cosmetics. It is intended to inform regulated industry about the Agency's current thinking on implementation of certain aspects, including the criteria, process, and expectations, for mandatory recalls of cosmetic products. The guidance announced in this notice finalizes the draft guidance of the same title published on December 18, 2025.

91 FR 66851FR Doc. 2026-21679official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentHealth Resources and Services Administration

Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: Advanced Nursing Education Program Specific Form OMB No. 0906-0089-Revision

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.

  • Comments close in 25 days

91 FR 66855FR Doc. 2026-21674official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentHealth Resources and Services Administration

Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners-45 CFR Part 60 Regulations and Forms, OMB No. 0906-0081-Revision

In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.

  • Comments close in 25 days

91 FR 66856FR Doc. 2026-21673official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentHealth Resources and Services Administration

National Vaccine Injury Compensation Program; List of Petitions Received

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.

91 FR 66859FR Doc. 2026-21672official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentSubstance Abuse and Mental Health Services Administration

HHS Approval of Entities That Certify Medical Review Officers

This notice publishes a list of HHS approved Medical Review Officers (MROs) certification entities. The most recent HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), effective on October 10, 2023, (Oral Fluid) and February 1, 2024, (Urine), address the role and qualifications of MROs and HHS approval of entities that certify MROs.

  • Takes effect 6 days ago

91 FR 66864FR Doc. 2026-21671official PDFfederalregister.gov

Proposed RuleHealth and Human Services DepartmentFood and Drug Administration

Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a draft guidance for industry entitled "Action Levels for Cadmium in Processed Food Intended for Babies and Young Children." The draft guidance, when finalized, will establish action levels for cadmium in certain processed foods intended for babies and young children less than 2 years old. The draft guidance is intended to set achievable action levels that will help further reduce cadmium in the food supply.

  • Comments close in 54 days

91 FR 66796FR Doc. 2026-21670official PDFfederalregister.gov

Proposed RuleHealth and Human Services DepartmentFood and Drug Administration

Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of one additional draft chapter of a multichapter draft guidance for industry titled "Hazard Analysis and Risk-Based Preventive Controls for Human Food." This multichapter draft guidance, when finalized, will explain FDA's current thinking on how to comply with the requirements for hazard analysis and risk-based preventive controls under FDA's regulation titled "Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food." The newly available draft chapter is titled "Chapter 12: Control of Chemical Hazards." This draft guidance is not final nor is it in effect at this time.

  • Comments close in 84 days

91 FR 66798FR Doc. 2026-21669official PDFfederalregister.gov

NoticeHealth and Human Services DepartmentIndian Health Service

Request for Public Comment: 60-Day Notice for Reinstated Collection: Division of Urban Indian Affairs Uniform Data System and Budget Formulation

In compliance with the Paperwork Reduction Act of 1995, the Indian Health Service (IHS) invites the public to comment on the information collection titled, "Division of Urban Indian Affairs (DUIA) Uniform Data System and Budget Formulation," Office of Management and Budget (OMB) Control Number 0917-0007. The IHS is requesting OMB to approve a reinstated collection.

  • Comments close in 54 days

91 FR 66860FR Doc. 2026-21644official PDFfederalregister.gov

Earlier

50 further days of this agency's activity are in the long-form archive, oldest to newest, on one page.

Everything Health and Human Services Department has published, 2026-08-10 to 2026-10-29 →

Ask an assistant instead

Everything on this page is also a tool call. Add mcp.downstream.sh as an MCP server in Claude, ChatGPT, or any client that speaks the protocol — no key, no account — then paste this:

Using the Downstream MCP server at mcp.downstream.sh, call whats_new_since with agency "Health and Human Services Department" since 2026-10-23, then summarise what changed and list every deadline it created.

Reaches whats_new_since. The response carries its own citations and states what it is missing — including which dates it has no record for.